World Investment Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$602K Sell
3,060
-192
-6% -$37.7K 0.01% 877
2026
Q1
$637K Buy
3,252
+519
+19% +$101K 0.01% 881
2025
Q4
$474K Buy
2,733
+100
+4% +$18.2K 0.01% 948
2025
Q3
$502K Buy
2,633
+10
+0.4% +$1.77K 0.01% 784
2025
Q2
$471K Buy
2,623
+68
+3% +$11.8K 0.01% 755
2025
Q1
$432K Buy
2,555
+79
+3% +$13K 0.01% 735
2024
Q4
$374K Buy
2,476
+270
+12% +$42K 0.01% 745
2024
Q3
$343K Sell
2,206
-31
-1% -$4.63K 0.01% 694
2024
Q2
$306K Buy
2,237
+315
+16% +$43.1K 0.02% 495
2024
Q1
$256K Buy
+1,922
New +$249K 0.04% 331

Other funds holding DGX

World Investment Advisors's DGX Position: Q2 2026 in Review

World Investment Advisors reduced its Quest Diagnostics (DGX) stake by 5.9% in Q2 2026, selling an estimated $37.7K and leaving 3,060 shares worth $602K. The position accounts for 0.01% of the portfolio, ranked #877.

World Investment Advisors first reported a position in DGX in Q1 2024 and has held it in 10 quarters since. The position peaked at $637K in Q1 2026. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • World Investment Advisors held 3,060 shares of Quest Diagnostics worth $602K as of Q2 2026.
  • World Investment Advisors sold 192 Quest Diagnostics shares in Q2 2026, an estimated $37.7K.
  • Quest Diagnostics made up 0.01% of World Investment Advisors's portfolio in Q2 2026, its #877 holding.
  • World Investment Advisors first reported a position in Quest Diagnostics in Q1 2024 and has held it in 10 quarters since.
  • World Investment Advisors's Quest Diagnostics position peaked at $637K in Q1 2026.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.